Curaleaf Holdings, Inc. (TSX: CURA)
Health Care · Pharmaceuticals · US
CA$13.31
-6.33% today · -0.7% 1Y
Curaleaf Holdings, Inc. (TSX: CURA) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $2.47B and employs 5,554 people.
Over the last twelve months the share price has lost 0.7%, trading between 7.77 and 20.93.
Tweenvest scores Curaleaf Holdings, Inc. across four factors: quality 48/100, value 52/100, growth 33/100. Its strongest factor is value.
CURA price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.47B
- Revenue (TTM)
- $1.32B
- P/E
- —
- EPS
- -0.20
- Dividend yield
- —
- Beta (5Y)
- 1.60
- 52-week high
- CA$20.93
- 52-week low
- CA$7.77
- Avg volume (3M)
- —
- Shares outstanding
- 264.81M
- Employees
- 5,554
- Next earnings
- —
About Curaleaf Holdings, Inc.
Curaleaf Holdings, Inc. operates as a prominent cannabis company primarily within the United States, managing its business through both domestic and international operating segments. The company's core activities involve the cultivation, production, and distribution of a diverse range of cannabis products, available through both its retail locations and wholesale channels. Its extensive product catalog includes various cannabis forms such as flowers (e.g., pre-rolls, dry-herb vaporizer cartridges), concentrates for vaping (like pre-filled cartridges and disposable pens), concentrates for dabbing (including distillate droppers), edibles, mints, topical balms, lotions, tinctures, lozenges, and capsules. Additionally, Curaleaf provides hemp-derived CBD and cannabigerol products. Established in 2010, the company is headquartered in New York, New York.
- ISIN
- CA23126M3003
- Listed since
- Apr 7, 2021
- Exchange
- The Toronto Stock Exchange
- Currency
- CAD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Rubicon Research LimitedNSEI: RUBICON | $2.65B | Rs1,548.50 | -5.05% |
| MBX Biosciences, Inc.NasdaqGS: MBX | $2.56B | $53.24 | -9.01% |
| China Resources Double-Crane Pharmaceutical Co.,Ltd.SHSE: 600062 | $2.53B | CN¥16.44 | +1.23% |
| Supernus Pharmaceuticals, Inc.NasdaqGM: SUPN | $2.48B | $42.67 | +0.68% |
| Almirall, S.A.BME: ALM | $2.46B | €10.08 | +0.20% |
| Liquidia CorporationNasdaqCM: LQDA | $2.45B | $27.38 | -2.28% |
| Aether Industries LimitedNSEI: AETHER | $2.40B | Rs1,748.10 | +4.68% |
| Jamjoom Pharmaceuticals Factory CompanySASE: 4015 | $2.39B | SR128.00 | +0.95% |
Figures last refreshed Oct 11, 2026.